FDA Inspection 809472 — NPS Pharmaceuticals Inc.

NPS Pharmaceuticals Inc. — FEI 3000244120

The FDA completed an inspection of NPS Pharmaceuticals Inc. on Dec 4, 2012 in Bedminster, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 4, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bedminster, NJ (United States)

Additional details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
748221 CFR 312.50General responsibilities of sponsors
748721 CFR 312.59Unused drug disposition (sponsor)
750721 CFR 312.52(a)Transfer of obligations
755421 CFR 312.53(c)(4)Financial information - sufficient and accurate

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.